Jorg Moller is the founder of Antag Therapeutics. Antag Therapeutics has raised $86M in total funding. Latest round: Series A.
Jörg Möller is the Chief Executive Officer at Antag Therapeutics, a biotechnology company developing peptide-based therapies for obesity and related cardiometabolic disorders. He has over 30 years of industry experience, previously serving as Corporate EVP and Head of Global R&D at Bayer AG and LEO Pharma. The company recently announced an €80 million Series A financing round.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide